C12N 2795/10243
Viral genome or elements thereof as genetic vector
Official title: viral genome or elements thereof as genetic vector
C12N2795/10243 (Viral genome or elements thereof as genetic vector) appears on 25 US grants and 38 published applications in this corpus.
Search patents in C12N- Granted patents
- 25
- Published applications
- 38
- Assignees
- 24
- Inventors
- 81
- Latest grant
- 28 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 1 |
| 2004 | 0 | 2 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 2 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 2 | 1 |
| 2013 | 0 | 2 |
| 2014 | 0 | 0 |
| 2015 | 2 | 3 |
| 2016 | 1 | 1 |
| 2017 | 1 | 2 |
| 2018 | 0 | 3 |
| 2019 | 4 | 2 |
| 2020 | 1 | 2 |
| 2021 | 1 | 3 |
| 2022 | 3 | 3 |
| 2023 | 4 | 3 |
| 2024 | 3 | 4 |
| 2025 | 0 | 1 |
| 2026 | 1 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods and systems for the rapid detection of Listeria using infectious agents28 Jul 2026US 12,692,482 B2Laboratory Corporation of America Holdings
- Methods and systems for rapid detection of microorganisms using infectious agents11 Jun 2024US 12,006,531 B2Laboratory Corporation of America Holdings
- Production of lytic phages9 Apr 2024US 11,952,595 B2Eligo Bioscience
- Production bacterial cells and use thereof in production methods26 Mar 2024US 11,939,598 B2Eligo Bioscience
- Production of lytic phages29 Aug 2023US 11,739,304 B2Eligo Bioscience
- Methods and Systems for the Rapid Detection of Microorganisms Using Recombinant Infectious Agents to Express an Indicator Subunit25 Jun 2026US 2026/0176667 A1Laboratory Corporation of America Holdings
- Systems for production of transducing particles, methods, kits, compositions and uses thereof26 Mar 2026US 2026/0083787 A1Ramot at Tel-Aviv University Ltd.
- Genetic engineering of bacteriophages using crispr-cas13a8 May 2025US 2025/0145968 A1The Regents of the University of California
- Production of lytic phages25 Jul 2024US 2024/0247238 A1Eligo Bioscience
- Production bacterial cells and use thereof in production methods6 Jun 2024US 2024/0182870 A1Eligo Bioscience
Most cited
By later US patents
- Inducible nitric oxide synthase gene for treatment of disease36US 5,658,565 AUniversity of Pittsburgh—Of the Commonwealth System of Higher Education · 1997
- Stable mammalian cell line expressing a bacteriophage RNA polymerase17US 5,126,251 AThe United States of America, as represented by the Secretary, Department of Health and Human Services · 1992
- Engineered enzymatically active bacteriophages and methods of uses thereof17US 8,182,804 B1Massachusetts Institute of Technology · 2012
- Methods and systems for rapid detection of microorganisms using infectious agents9US 10,519,483 B2Laboratory Corporation of America Holdings · 2019
- Infectious cDNA of an approved vaccine strain of measles virus, use for immunogenic compositions7US 9,005,925 B2Centre National De La Recherche Scientifique · 2015